DS
PPH icon

David Shaw’s VanEck Pharmaceutical ETF PPH Stock Holding History

David Shaw’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-27,851
Closed -$2.52M – 4918
2025
Q3 		$2.52M Sell
27,851
-2,403
-8% -$210K ﹤0.01% 2803
2025
Q2 		$2.66M Buy
+30,254
New +$2.62M ﹤0.01% 2530
2025
Q1 		– Sell
-3,933
Closed -$339K – 4635
2024
Q4 		$339K Sell
3,933
-20,535
-84% -$1.86M ﹤0.01% 3826
2024
Q3 		$2.33M Buy
24,468
+10,180
+71% +$967K ﹤0.01% 2604
2024
Q2 		$1.31M Sell
14,288
-23,100
-62% -$2.06M ﹤0.01% 3000
2024
Q1 		$3.39M Buy
+37,388
New +$3.27M ﹤0.01% 2203

Other funds holding PPH

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $16B AUM 37.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

David Shaw's PPH Position: Q4 2025 in Review

David Shaw sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2025, closing a stake of 27,851 shares — an estimated $2.52M sold.

David Shaw first reported a position in PPH in Q1 2024 and held it in 6 quarters. The position peaked at $3.39M in Q1 2024. 146 funds tracked by Wall St. Rank hold PPH as of Q4 2025.

  • David Shaw reported no remaining VanEck Pharmaceutical ETF position as of Q4 2025 after selling out during the quarter.
  • David Shaw sold 27,851 VanEck Pharmaceutical ETF shares in Q4 2025, an estimated $2.52M.
  • David Shaw first reported a position in VanEck Pharmaceutical ETF in Q1 2024 and held it in 6 quarters.
  • David Shaw's VanEck Pharmaceutical ETF position peaked at $3.39M in Q1 2024.
  • 146 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2025.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.